Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent

Dean R. Artis, Jack J. Lin, Chao Zhang, Weiru Wang, Upasana Mehra, Mylene Perreault, David Erbe, Heike I. Krupka, Bruce P. England, James Arnold, Alexander N. Plotnikov, Adhirai Marimuthu, Hoa Nguyen, Sarah Will, Maxime Signaevsky, John Kral, John Cantwell, Calvin Settachatgull, Douglas S. Yan, Daniel FongAngela Oh, Shenghua Shi, Patrick Womack, Benjamin Powell, Gaston Habets, Brian L. West, Kam Y.J. Zhang, Michael V. Milburn, George P. Vlasuk, K. Peter Hirth, Keith Nolop, Gideon Bollag, Prabha N. Ibrahim, James F. Tobin

Research output: Contribution to journal › Article › peer-review

113 Scopus citations

Fingerprint

Dive into the research topics of 'Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent'. Together they form a unique fingerprint.

Medicine & Life Sciences